Aims: To analyze brain functional connectivity in the somatomotor and default-mode networks (DMNs) of patients with Huntington disease (HD), its relationship with gray matter (GM) volume loss, and functional changes after pridopidine treatment. 
| INTRODUCTION
Huntington disease (HD), an autosomal-dominant disease determined by a cytosine-adenine-guanine (CAG) expansion mutation in the HTT gene encoding the protein huntingtin, results in progressive neuronal degeneration, motor and behavioral disturbances, and cognitive deficits. More CAG repeats result in earlier disease onset. 1 Reliable individual-level markers of brain changes would allow evaluation of treatment efficacy and monitoring of disease progression. Current structural imaging studies have described reduced caudate and putamen volumes, cortical thinning, and early impairment of white matter fibers. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Network-sensitive neuroimaging techniques have shown that spatial pattern of atrophy of a disease relates to functional connectivity, as mapped by resting-state functional magnetic resonance imaging (fMRI). 16 explain why some lesions are particularly disruptive, 18 how the neurodegenerative process spreads across functionally interconnected brain regions, 16 and how a potential drug may modify these connections.
Literature on multimodal (fMRI, electroencephalography, and magnetoencephalography) imaging [19] [20] [21] [22] supports evidence of RSNs, among which the somatomotor network (SMN) and default-mode network (DMN) are typically very reproducible. DMN is characterized by greater activation during rest than during goal-directed tasks, suggesting network activity reflects a default state of neuronal activity of the human brain 18, [23] [24] [25] [26] It comprises the posterior cingulate cortex (PCC), medial frontal and inferior parietal regions, and plays a fundamental role in integration across different functional domains. 27 We previously identified the PCC and supplementary motor area (SMA) as core regions for the DMN and SMN, respectively. 21 DMN is a backbone around which other cortical networks amalgamate with the PCC, acting as a major transit hub for exchange of information.
21
Furthermore, the SMA has been associated with planning, preparation, and execution of voluntary movements. It is involved in the corticospinal tract and has anatomical connections with the primary motor cortex and basal ganglia, 21 areas known to be impaired in HD.
It is unclear whether the DMN is impaired during the presymptomatic stage [28] [29] [30] [31] [32] or from manifest HD. Some studies have shown reduced functional connectivity in DMN-related areas, such as the PCC, ventromedial prefrontal cortex (vmPFC), and angular gyrus, 33 while others have highlighted the functional connectivity increase. 34, 35 Regarding the SMN, functional connectivity increase has been described, 35, 36 suggesting a compensatory process due to striatal or cortical degeneration, or a generalized spreading of activity due to reduced specialization of function. 37 Longitudinal studies in presymptomatic subjects showed no differences compared with controls over time. 38, 39 Alterations in dopamine and dopamine-receptor levels in the brain contribute to clinical symptoms of HD. 40 Pridopidine, a new dopamineligand compound, is thought to stabilize dysregulated psychomotor functions, by modulating hyper-or hypo-active functioning in areas of the brain receiving dopamine input. 41 Pridopidine showed potential neuroprotective properties through interaction with the sigma-1 receptor. 41, 42 In a Phase III study, pridopidine improved total motor score (TMS) on the Unified Huntington's Disease Rating Scale (UHDRS) 43 without worsening cognitive or psychiatric symptoms after 1 year.
44
To date, pharmacological effects of pridopidine on functional connectivity, mapped by fMRI, have not been reported in patients with HD.
The aim of our study is to analyze brain functional connectivity in the SMN and DMN in HD patients, its relationship with gray matter (GM) volume loss, and functional changes after short-term treatment with pridopidine 90 mg/d.
| METHODS

| Patients
Ten HD patients with CAG repeat expansions ranging from 42 to 66, and 10 age-and gender-matched controls were enrolled. All patients were clinically examined by the same neurologist (F.S.) using the UHDRS motor, cognitive, behavioral, and functional subscales. 45 
| MRI data processing
| fMRI preprocessing
The preprocessing pipeline was performed using a combination of 
| Computation of functional connectivity maps
The adopted measure of functional connectivity is based on the Pearson correlation coefficient computed among BOLD time series of brain voxels. To reduce the computational burden, data were interpolated to a final voxel size of 4×4×4 mm using a second-order nearest-neighbor interpolation (FSL interpolation tool). We standardized brains in Montreal Neurological Institute (MNI) space and selected a common brain space including only voxels present in all the subjects of a group. The brains in MNI space consisted of 25 806 common voxels for the control group and 25 921 common voxels for the patient's sample. To obtain the DMN and SMN connectivity maps, we used a seed-based approach by adopting the PCC and SMA as seeds corresponding to the MNI coordinates reported previously. 21 To obtain a more robust estimate, we computed the average BOLD time course within a cube of 3 voxels centered on each seed, which we correlated with the rest of the brain. 
| Whole-brain analysis of gray matter volume
The structural stability of the main nodes of both networks was evaluated using structural data (T1 images) by an optimized voxel-based 
| FreeSurfer analysis
To perform a correlation analysis between functional connectivity and GM volume, we estimated the absolute GM volume of the con- 
| RESULTS
Demographic data are reported in Table S1 . There were no significant differences in age or gender distribution between groups (P<.05).
| Resting-state networks
| Gray matter analysis
The analysis of GM showed structural impairment in all cortical and subcortical areas involved in SMN, with preservation of SMA ( Figure 1 , yellow arrows). There was global structural preservation of all cortical areas of the DMN (Figure 1, red arrows) . The most significant GM loss occurred in the caudate, putamen, globus pallidus, and thalamus bilaterally; the primary somatomotor and somatosensory areas bilaterally (pre-and postcentral gyri, supramarginal gyrus), the left precuneus, and right lingual gyrus.
| Somatomotor network functional topography
SMN functional connectivity is impaired in HD patients compared with controls. Figure 2 shows the spatial topography of the SMN obtained when the seed is the SMA. The SMA is connected with the pre-SMA and primary somatomotor and somatosensory areas in controls, whereas in patients, there is an aberrant spread of significant connections between the SMA and premotor, medial prefrontal, anterior cingulate, and primary somatomotor and somatosensory areas.
We computed the percentage overlap between patients' and controls' connectivity maps and percentage difference in overall connectivity between groups. After calculating the total number of significant connections with SMA as seed (P<.05, FDR-corrected; Figure 2 ), obtaining 5789 connections for the patients and 827 connections for controls;
we computed a mask of the common connections across patients and controls, namely 599 common connections, and normalized the num- (Table S3) . We also calculated the intensity of significant connections at time 1 and time 2 and its 
| Default-mode network functional topography
| Resting-state networks: functional architecture
| Nodal degree of connectivity
To test whether the centrality of a hub influences its preservation during the neurodegenerative process, we adopted a graph measure of centrality: the nodal degree. We evaluated the mean degree obtained, for every node, by averaging its degree of connectivity across the whole brain. We defined nodes showing a high degree as those whose degree exceeded the threshold [mean+two standard deviations (2SD) of estimated degree values] (dashed line in Figure 5A ), which were PCC for the DMN, and the SMA and primary motor and somatosensory areas for the SMN (bars in Figure 5A ).
| Correlation between node centrality and clinical and genetic data
The number of CAG repeats significantly correlates with degree of connectivity in PCC (P=.02; r=−.696; Figure 5B ), the main hub of the DMN. For SMA, the correlation was not significant, but a negative trend was observed (left SMA: P=.1; right SMA: P=.2; Figure 5C ). No other nodes showed any significant correlation with the number of CAG repeats, suggesting that node centrality in the PCC and SMA is inversely related to number of CAG repeats.
Among the remaining DMN nodes, the vmPFC degree correlated negatively with TMS (r=−.878; P=.001), and positively with the symbol digit score (r=.715; P=.04) and TFC (r=.618; P=.05) (Fig. S1A) (Fig. S1B) . 
| DISCUSSION
The aim of our study was to investigate changes in fMRI of the SMN and DMN in HD patients and their correlation with the genetic burden, clinical scores, and GM loss.
Our findings show the following: (i) increased functional connectivity in both the SMN and DMN in HD patients that preceded the GM volume loss in the DMN; (ii) the centrality value (degree) of the PCC and SMA showed an inverse relationship with number of CAG repeats;
and the centrality value of the vmPFC and right putamen correlated with patients' clinical and genetic data.
Structural data showed HD patients have increased GM loss compared with controls in the majority of nodes of the SMN network, apart from the SMA. Areas of significant GM loss were the caudate, putamen, globus pallidus, thalamus, and primary somatomotor and somatosensory areas, consistent with previous published studies. [6] [7] [8] 11, 12 Interestingly, SMA volume is preserved in our sample and correlates to its increased functional connectivity. We speculate it might be linked to the central role of SMA as a hub, which allows the SMN to integrate with other functional circuits. These results seem to suggest a pattern of damage from local to more central nodes.
The functional connectivity of the SMN showed HD patients having a 85% increase in functional connectivity compared with controls.
The degree of functional connectivity in the right putamen, a critical SMN node affected early in HD, correlated with cognitive and behavioral measures in our cohort. Interestingly, the higher the connectivity was in the right putamen, the better the cognitive performance and less severe the obsessive-compulsive behavior, a frequently occurring psychiatric manifestation in HD 52 Together, these results suggest increased functional connectivity in the SMN in HD patients could represent a compensatory mechanism to maintain motor and cognitive F I G U R E 4 Average DMN maps of the HD and control groups. FDR-corrected, P<.05. AG, angular gyrus; mPFC, medial prefrontal cortex; PCC, posterior cingulate cortex; SMA, supplementary motor area performance. 36 Consistent with our results, previous studies showed increased functional connectivity in areas related to motor function in HD, which was correlated with motor and cognitive functioning. 35, 36 Increased connectivity in the putamen, together with other striatalprefrontal structures, has been related to improved performance in a Stroop task in different cohorts (ie, Parkinson disease patients, cocaine-dependent subjects, and middle-aged healthy subjects). [53] [54] [55] Thus, stronger putaminal connectivity reflects compensatory strategies to meet task demands and improve performance levels. Furthermore, the putamen underlies obsessive-compulsive traits. [56] [57] [58] Obsessivecompulsive disorder patients have reduced functional connectivity between the putamen and prefrontal areas 56, 58 and the volume and shape of the putamen correlate with obsessive-compulsive symptoms in healthy subjects. 57 Previous task-related fMRI studies have also shown enhanced activation in HD patients as a compensatory process due to striatal or cortical degeneration. [38] [39] [40] Thus, in HD patients, the functional connectivity will be increased by the regulatory role of dopamine that the striatal impairment exerts in this circuit; and by the cumulative effect of diffuse cortical structural alterations, altogether causing the characteristic deterioration in motor and cognitive functions. The DMN is active when individuals are engaged offline, internally focused tasks. 59 There is evidence that despite progressive GM volume loss, clinical measures do not necessarily deteriorate in HD gene-mutation carriers. This fact supports that neural activity reorganizes to maintain normal behavior despite the loss of brain volume, as a "neural compensation". 36 Our results support this hypothesis by showing a relationship between vmPFC connectivity and specific cognitive functions in HD. Previous studies reported contradictory results regarding DMN connectivity in HD patients. These differences might be due to different methodologies used, as well as clinical differences (our subjects have more CAG repeats and are younger).
Dumas et al. 33 used networks of interest obtained by an Independent
Component Analysis as reference for the connectivity estimation. In our work, we adopted a seed-based approach, thus using a region as reference. This may lead to differences in the change in connectivity.
In particular, our results show connectivity changes with respect to a given region (PCC), while other results assume an identical signal belonging to each identified network between regions. In addition, the regression steps that remove the ventricles and global signal contributions are known to induce negative connectivity values and thus affect the number of significant connections. 50 Notably, there are other studies supporting the finding in HD patients of increased connectivity, which has been discussed as a compensatory process [34] [35] [36] or as a generalized spreading of activity due to reduced specialization of function.
37
Our study is limited by the overall small population and small sample of patients treated with pridopidine. Although the purpose of this study was only to investigate fMRI as a valuable technique for monitoring pharmacological effects in HD patients, preliminary data open the possibility of extending the sample in a longitudinal, multicentric, clinical, imaging study. If treatment goal is to improve cerebral function, both structural and functional imaging may predict whether an individual will respond to a particular treatment. However, therapeutic
conclusions cannot be extracted.
In conclusion, our preliminary data describe, to our knowledge for 
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